Skip to Content
David F Jarrard, MD

Contact Dr. Jarrard


(608) 262-0759

UW Medical Foundation Centennial Building
1685 Highland Ave
MADISON, WI 53705-2281

David F Jarrard, MD

Vice Chair for Clinical Affairs
Professor of Urology
John Livesey Chair in Urologic Oncology


  • MD, University of Virginia School of Medicine, Charlottesville, VA, 1989
  • Junior Residency in General Surgery, University of Chicago, Chicago, IL, 1989-1990
  • Residency in Urology, University of Chicago, Chicago, IL, 1990-1994
  • Fellow in Urologic Oncology, American Foundation for Urologic Disease, Johns Hopkins University, Baltimore, MD, 1994-1996

Clinical Specialties

Dr. Jarrard is board certified by the American Board of Urology and has completed a fellowship in Urologic Oncology. He specializes in all aspects of urologic oncology with an emphasis on prostate cancer diagnosis and treatment including robotics.

Research Interests

Dr. Jarrard has a joint appointment with the University of Wisconsin Comprehensive Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health to examine genetic and epigenetic alterations in prostate cancer.

Dr. Jarrard's lab

  • The Induction of Cellular Senescence as Therapy for Advanced Prostate Cancer
    Funding Agency: Prostate Cancer Foundation
    Principal Investigator(s): David F Jarrard, MD
    More Information

Recent Publications
  • Blute ML, Damaschke NA, Jarrard DF. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications. Curr Opin Urol 2015 Jan; 25(1):83-8.
    [PubMed ID: 25405932]
    More Information
  • Damaschke NA, Yang B, Blute ML, Lin CP, Huang W, Jarrard DF. Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer. Neoplasia 2014 Dec; 16(12):1018-27.
    [PubMed ID: 25499215, PMCID: 4309256]
    More Information
  • Keil KP, Abler LL, Laporta J, Altmann HM, Yang B, Jarrard DF, Hernandez LL, Vezina CM. Androgen receptor DNA methylation regulates the timing and androgen sensitivity of mouse prostate ductal development. Dev. Biol. 2014 Dec 15; 396(2):237-45.
    [PubMed ID: 25446526, PMCID: 4261055]
    More Information
  • Jarrard DF, Blute ML, Ritter MA. Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer. J. Clin. Oncol. 2014 Dec 10; 32(35):3926-9.
    [PubMed ID: 25332250]
    More Information
  • Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur. Urol. 2014 Dec; 66(6):1139-47.
    [PubMed ID: 25194909]
    More Information
  • Abel EJ, Wong K, Sado M, Leverson GE, Patel SR, Downs TM, Jarrard DF. Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS 2014 Apr-Jun; 18(2):282-7.
    [PubMed ID: 24960494, PMCID: 4035641]
    More Information
  • Yang B, Wagner J, Damaschke N, Yao T, Wuerzberger-Davis SM, Lee MH, Svaren J, Miyamoto S, Jarrard DF. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation. PLoS ONE 2014; 9(2):e88052.
    [PubMed ID: 24558376, PMCID: 3928145]
    More Information
  • Abel EJ, Bauman TM, Weiker M, Shi F, Downs TM, Jarrard DF, Huang W. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum. Pathol. 2014 May; 45(5):1092-9.
    [PubMed ID: 24746216, PMCID: 4134351]
    More Information
  • Truong M, Slezak JA, Lin CP, Iremashvili V, Sado M, Razmaria AA, Leverson G, Soloway MS, Eggener SE, Abel EJ, Downs TM, Jarrard DF. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer 2013 Nov 15; 119(22):3992-4002.
    [PubMed ID: 24006289]
    More Information
  • Damaschke NA, Yang B, Bhusari S, Svaren JP, Jarrard DF. Epigenetic susceptibility factors for prostate cancer with aging. Prostate 2013 Dec; 73(16):1721-30.
    [PubMed ID: 23999928, PMCID: 4237278]
    More Information Copyright © 2015 The Board of Regents of the University of Wisconsin System